์ฃผ์š” ์ฝ˜ํ…์ธ ๋กœ ๊ฑด๋„ˆ๋›ฐ๊ธฐ

๊ท€ํ•˜์˜ ๋ธŒ๋ผ์šฐ์ €๊ฐ€ ์™„๋ฒฝํ•˜๊ฒŒ ์ง€์›๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค. ์˜ต์…˜์ด ์žˆ๋Š” ๊ฒฝ์šฐ ์ตœ์‹  ๋ฒ„์ „์œผ๋กœ ์—…๊ทธ๋ ˆ์ด๋“œํ•˜๊ฑฐ๋‚˜ Mozilla Firefox, Microsoft Edge, Google Chrome ๋˜๋Š” Safari 14 ์ด์ƒ์„ ์‚ฌ์šฉํ•˜์„ธ์š”. ๊ฐ€๋Šฅํ•˜์ง€ ์•Š๊ฑฐ๋‚˜ ์ง€์›์ด ํ•„์š”ํ•œ ๊ฒฝ์šฐ ํ”ผ๋“œ๋ฐฑ์„ ๋ณด๋‚ด์ฃผ์„ธ์š”.

Elsevier
์—˜์Šค๋น„์–ด์™€ ํ•จ๊ป˜ ์ถœํŒ

ํ”„๋กœํ•„

Ali Ellebedy

Ali Ellebedy

Session title: Models for Vaccine Development and Evaluation

WashU Medicine, USA

Ali Ellebedy is a viral immunologist whose research centers on B cell responses to viral infections and vaccination. He holds the title Leo Loeb Endowed Professor in Pathology & Immunology. He is the Co-Director of the Center for Vaccines and Immunity to Microbial Pathogens at Washington University School of Medicine in St Louis, MO, USA. His research interests include: 1) How persistent germinal center reactions are induced and persist after vaccination. 2) The mechanisms underlying the induction of broadly neutralizing antibody responses to rapidly evolving viruses (e.g., influenza, coronaviruses).